☆ 4.5 Article

COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease

TRANSLATIONAL ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Long-term cardiovascular outcomes of COVID-19

Yan Xie et al.

Summary: Individuals with COVID-19, even those who were not hospitalized during the acute phase of the infection, are at an increased long-term risk of various cardiovascular disorders. A study using national healthcare databases found that beyond the first 30 days after infection, individuals with COVID-19 have an elevated risk of developing cerebrovascular disorders, heart diseases, and other cardiovascular complications. The risk increases depending on the care setting during the acute phase.

NATURE MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19

Csilla Varnai et al.

Summary: This study finds no association between recent systemic anticancer treatments and COVID-19 mortality in patients with active cancer, suggesting that cancer treatments do not inferior outcomes. Differences in outcomes among patients with different cancer types were observed.

JAMA NETWORK OPEN (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19

Mariana Corrochano et al.

Summary: The study found that chronic anticoagulation therapy prior to hospitalization for COVID-19 was associated with lower ICU admission rates, but there were no significant differences in mortality between the patients receiving chronic antithrombotic therapy and patients not taking antithrombotic medications.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)

Add to Collection

Article Medicine, General & Internal

Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19

Jose Miguel Rivera-Caravaca et al.

Summary: Patients with COVID-19 who were on oral anticoagulation therapy at hospital admission showed lower survival and higher mortality risk compared to those without prior OAC. High prevalence of comorbidities was observed in these patients on OAC therapy. Respiratory insufficiency, systemic inflammatory response syndrome during hospitalization, and higher comorbidity were identified as main risk factors for increased mortality in anticoagulated patients.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Medicine, General & Internal

Direct oral anticoagulant use and risk of severe COVID-19

B. Flam et al.

Summary: The study found that ongoing DOAC use was not associated with reducing the risk of severe COVID-19, suggesting that early outpatient DOAC initiation would not modify prognosis.

JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation

Sean X. Gu et al.

Summary: Platelet and endothelial dysfunction are essential components of COVID-19 pathology, while cardiovascular risk factors exacerbate the severity of the disease. Patients with pre-existing cardiovascular disease and risk factors are at the highest risk of death from COVID-19.

NATURE REVIEWS CARDIOLOGY (2021)

Add to Collection

Review Infectious Diseases

Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors

Tingxuan Yin et al.

Summary: A systematic review and meta-analysis found that while some comorbidities had lower prevalence in COVID-19 patients compared to the general population, they were more common in severe cases. Among these, cerebrovascular disease was identified as the strongest risk factor for disease exacerbation, followed by chronic kidney disease, chronic obstructive pulmonary disease, cardiovascular disease, malignancy, diabetes, and hypertension.

BMC INFECTIOUS DISEASES (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study

Richard Chocron et al.

Summary: The study found that COVID-19 patients receiving anticoagulation therapy before hospitalization had a better prognosis, while those starting anticoagulation therapy during hospitalization were not associated with any outcomes. Early introduction of anticoagulation therapy can help prevent COVID-19-associated coagulopathy and endotheliopathy, leading to a better prognosis for patients.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Add to Collection

Article Oncology

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

P. Grivas et al.

Summary: This study analyzed clinical factors and laboratory measurements of cancer patients with COVID-19, finding that factors such as age, sex, comorbidities, cancer type, and laboratory results were associated with COVID-19 severity. Patients diagnosed early in the pandemic had worse outcomes, and specific anticancer therapies may increase 30-day all-cause mortality. More research is needed to confirm these findings and caution may be needed in using certain anticancer treatments.

ANNALS OF ONCOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Metoprolol in Critically Ill Patients With COVID-19

Agustin Clemente-Moragon et al.

Summary: In this study, metoprolol treatment in patients with COVID-19-associated ARDS was shown to be safe and effective in reducing lung inflammation and improving oxygenation, resulting in fewer days on invasive mechanical ventilation. Repurposing metoprolol for COVID-19-associated ARDS could be a cost-effective strategy to alleviate the burden of the pandemic.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease

Elena Tessitore et al.

Summary: Previous cardiovascular diseases are associated with higher in-hospital mortality and major adverse cardiovascular events in hospitalized patients with COVID-19. Other factors such as older age, male gender, and elevated CRP levels on admission also contribute to higher mortality rates.

OPEN HEART (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Zunyou Wu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Editorial Material Oncology

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

Wenhua Liang et al.

LANCET ONCOLOGY (2020)

Add to Collection

Editorial Material Oncology

The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer Comment

Samuel M. Rubinstein et al.

CANCER CELL (2020)

Add to Collection

Article Medicine, General & Internal

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

Lennard Y. W. Lee et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

Add to Collection

Review Endocrinology & Metabolism

Prevalence of co-morbidities and their association with mortality in patients withCOVID-19: A systematic review and meta-analysis

Awadhesh K. Singh et al.

DIABETES OBESITY & METABOLISM (2020)

Add to Collection

Letter Hematology

COVID-19 mortality in patients on anticoagulants and antiplatelet agents

Helena Sivaloganathan et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Add to Collection

Editorial Material Oncology

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

CANCER CELL (2020)

Add to Collection

Review Oncology

Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies

Kamal S. Saini et al.

EUROPEAN JOURNAL OF CANCER (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.